PrecisionOS has received FDA approval to market its virtual reality surgical planning tool.

PrecisionOS® has received a 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market InVisionOS™ a patient specific planning tool using Virtual Reality (VR). Surgeons can utilize an Oculus Quest 2 device to undertake preoperative planning with the patented software, which will be accessible in early 2022.

InVisionOS is a next generation patient specific planning tool. Currently surgeons view a simulated 3D image of the patient on a computer screen and then carry that mental model to the operating room. InVisionOS software automatically converts the patient’s computed tomography (CT) scan from any PACS system into a 3D reconstruction within seconds. Surgeons can then use the Oculus Quest 2 to view, manipulate and isolate relevant anatomical areas prior to performing the actual surgical procedure.

“We focus on developing products that improve the confidence, competency and proficiency of surgeons, ultimately benefiting patient outcomes,” says Danny Goel, M.D., CEO, PrecisionOS. “Our new InVisionOS software, which took four years to develop, allows surgeons to visualize patient specific needs and better plan for surgery.”

InVisionOS is a class-II medical device cleared under the FDA’s 510(k) premarket submission program, which required that the company demonstrate the safety and effectiveness of the device.

It seems that more companies become interested in using XR technology for health solutions. What do you think about the future of health industry in Metaverse?

Source

Leave a Comment